ANTIBODIES

Contributor Information
- Name Edward Chan
- Institute University of Florida Research Foundation
Tool Details
- Tool name: Anti-cancer inhibitor of protein phosphotase 2A [4A9-1A2]
- Alternate names: CIP2A
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human ; Rat ; Mouse
- Host: Mouse
- Application: WB ; IP
- Description: CIP2A is an oncoprotein that inhibits PP2A tumor suppressor activity in human malignancies by preventing degredation of c-Myc and regulates the phosphorylation of many oncoproteins. CIP2A is required for malignant cellular growth and tumor formation and is overexpressed in several human cancers: head and neck squamous cell carcimona, colon cancer, gastric cancer, breast cancer, prostate cancer, and lung caner.
- Immunogen: MAb were generated using the C-terminal third of the recombinant human protein as antigen
- Isotype: IgG1 kappa
- Research area: Cancer; Cell signaling and signal transduction
- For Research Use Only
Target Details
- Target: Cancerous Inhibitor of Protein Phosphatase 2A
- Target background: CIP2A is an oncoprotein that inhibits PP2A tumor suppressor activity in human malignancies by preventing degredation of c-Myc and regulates the phosphorylation of many oncoproteins. CIP2A is required for malignant cellular growth and tumor formation and is overexpressed in several human cancers: head and neck squamous cell carcimona, colon cancer, gastric cancer, breast cancer, prostate cancer, and lung caner.
Application Details
- Application: WB ; IP
Handling
- Format: Liquid
- Shipping conditions: Shipping at 4ðC
Related Tools
References
- • Wei et al. 2019. Oncol Lett. 17(3):3211-3218. PMID: 30867751.